ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Endo terminates $190M deal for sterile injectable player fiercepharma
March 03, 2019The Dublin-based Endo and its Par sterile injectables subsidiaries Wednesday?said?a $190 million agreement to buy sterile injectables company Somerset Therapeutics had been terminated without penalties because it was taking too long to complete.
Pharma Sources Insight January 2025
